IRIS
BIZZARRO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.948
NA - Nord America 3.972
AS - Asia 2.409
SA - Sud America 320
AF - Africa 23
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.683
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.425
US - Stati Uniti d'America 3.929
SG - Singapore 895
IE - Irlanda 778
CN - Cina 602
UA - Ucraina 443
GB - Regno Unito 364
HK - Hong Kong 351
DE - Germania 307
BR - Brasile 272
VN - Vietnam 199
FI - Finlandia 157
SE - Svezia 151
IT - Italia 134
TR - Turchia 113
IN - India 97
FR - Francia 60
GR - Grecia 58
KR - Corea 41
JP - Giappone 35
CA - Canada 25
BE - Belgio 21
BD - Bangladesh 17
AR - Argentina 15
MX - Messico 13
IQ - Iraq 11
CO - Colombia 10
ID - Indonesia 10
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
PL - Polonia 9
AU - Australia 7
EC - Ecuador 6
NL - Olanda 6
UZ - Uzbekistan 6
CL - Cile 5
ES - Italia 5
MY - Malesia 5
AT - Austria 4
MA - Marocco 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
LT - Lituania 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
EG - Egitto 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LU - Lussemburgo 2
PE - Perù 2
PH - Filippine 2
PK - Pakistan 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
SC - Seychelles 1
SN - Senegal 1
TN - Tunisia 1
Totale 13.683
Salva come PNG Salva come JPEG
Città #
Moscow 1.552
Dublin 777
Jacksonville 656
Chandler 530
Santa Clara 424
San Jose 392
Singapore 388
Hong Kong 347
Dallas 174
Ashburn 132
Princeton 110
New York 101
Medford 100
Ann Arbor 96
Boardman 96
Beijing 88
San Mateo 82
Bengaluru 78
Hefei 75
Munich 65
Wilmington 63
Ho Chi Minh City 62
Hanoi 56
Woodbridge 56
Helsinki 44
The Dalles 43
Düsseldorf 39
Seoul 35
Cambridge 26
Roxbury 26
Los Angeles 24
Brussels 21
Bremen 20
São Paulo 20
Nanjing 17
Orem 17
Auburn Hills 16
Shenyang 16
Venice 16
Caserta 15
Des Moines 14
Jinan 14
Norwalk 13
Guangzhou 12
Mountain View 12
Tianjin 11
Da Nang 10
Houston 10
Nanchang 9
Warsaw 9
Brno 8
Brooklyn 8
Rio de Janeiro 8
Rome 8
Salerno 8
Brasília 7
Dearborn 7
Frankfurt am Main 7
Hanover 7
Lanzhou 7
Naples 7
Ottawa 7
Tokyo 7
Zhengzhou 7
Atlanta 6
Chennai 6
Curitiba 6
Hải Dương 6
Istanbul 6
Kunming 6
San Francisco 6
Seattle 6
Tashkent 6
West Jordan 6
Cimitile 5
Dhaka 5
Elora 5
Haiphong 5
Hangzhou 5
Hillsboro 5
Johannesburg 5
Kocaeli 5
London 5
Minneapolis 5
Porto Alegre 5
Quảng Ngãi 5
Redwood City 5
Shanghai 5
Amsterdam 4
Ankara 4
Changsha 4
Haikou 4
Hebei 4
Montreal 4
Osasco 4
Shah Alam 4
Surabaya 4
Ansan-si 3
Baghdad 3
Belo Horizonte 3
Totale 7.287
Salva come PNG Salva come JPEG
Nome #
1) A new approach to the study of Graves Ophthalmopathy: Standardized A-Scan Echography and Octreotide scintigraphy as possible parameters for disease activity 438
A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity? 183
Diagnostic evaluation of a patient with suspected Cushing’s Syndrome and hyperandrogenism: metabolic and clinical aspects for a correct differential diagnosis 179
ective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? 179
Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 178
(2008). Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies. 2008 176
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 175
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 175
ANTIBODIES AGAINST GONADOTROPIN-SECRETING CELLS IN PATIENTS WITH KALLMANN’S SYNDROME AND IN PATIENTS WITH APPARENTLY IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM 174
Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up 173
Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism. 173
Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome. 171
Anticorpi antimuscolo oculare e molecole di adesione come markers immunologici nell' oftalmopatia basedowiana 167
[T-lymphocyte subpopulations in the conjunctiva of subjects with secondary Sjogren's syndrome] 163
Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism 162
Prospective investigation of pituitary functions in patients with acute infectious meningitis: is acute meningitis induced pituitary dysfunction associated with autoimmunity? 161
Characterization of pituitary cells targeted by antipituitary antibodies in patients with isolated autoimmune diseases without pituitary insufficiency may help to foresee the kind of future hypopituitarism. 160
Behavior of sICAM-1 and sELAM-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma 158
111In-octreotide in autoimmune thyroid disease and in the evaluation of active exophthalmos 157
Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity? 152
PREGNANCY MAY FAVOUR THE DEVELOPMENT OF SEVERE AUTOIMMUNE CENTRAL DIABETES INSIPIDUS IN WOMEN WITH VASOPRESSIN-CELL ANTIBODIES: DESCRIPTION OF TWO CASES 150
A new approach to the study of Graves Ophthalmopathy: Standardized A-Scan Echography and Octreotide scintigraphy as possible parameters for disease activity 150
Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects 150
111In-octreotide in the evaluation of autoimmune thyroid diseases 149
Anti-Pituitary Antibodies in Children With Newly Diagnosed Celiac Disease: A Novel Finding Contributing to Linear-Growth Impairment 146
Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies 146
[TAC-positive lymphocytes in Basedow's disease] 143
A new ELISA assay for islet cell surface antibodies determination in type 1 diabetes mellitus of recent onset 142
Peripheral blood mononuclear cell populations in men with "idiopathic" infertility with antisperm autoantibodies 141
Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus 140
[Serum tumor markers in lung neoplasms (correlation with histological types)] 137
Sindromi poliendocrine autoimmuni 137
[Effect of pretreatment with metoclopramide on plasma prolactin response to methergoline] 133
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidus 133
Relationship between Graves' ophthalmopathy activity and serum immunological markers (anti-ocular muscle antibody, soluble adhesion molecules) 130
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study 129
[Effect of cyproheptadine on plasma ACTH and cortisol secretion in a patient with Cushing's disease] 128
Cytomegalovirus and male infertility 128
[Autoimmune Addison's disease. Current knowledge and prospects] 127
PITUITARY ANTIBODIES AND LYMPHOCYTIC HYPOPHYSITIS 126
T-lymphocyte subsets in pregnant women with Graves' disease 125
Hashimoto’s thyroiditis and entero-chromaffin-like cell hyperplasia: early detection and somatostatin analogue treatment. 124
Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity 123
Immunological and clinical aspects of lymphocytic hypophysitis 122
Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease 122
Subclinical diabetes insipidus 122
Italian Addison network study: update of diagnostic criteria for the etiological classification of primary adrenal insufficiency 121
[Effects of pentobarbital on serum levels of LH and FSH, in normal conditions and after GnRH stimulation: preliminary report] 121
Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature 121
[Anti-rubella antibodies in neapolitan females. Correlation with age and work (author's transl)] 121
Late primary autoimmune hypothyroidism in a patient with postdelivery autoimmune hypopituitarism associated with antibodies to growth hormone and prolactin-secreting cells. 120
[Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease] 120
Indio-111 Octreotide nelle malattie tiroidee autoimmuni e nella oftalmopatia attiva 120
CD11B lymphocytes in type 1 diabetes mellitus of recent onset 119
neoplasie endocrine multiple 119
Longitudinal behavior of autoimmune GH deficiency: from childhood to transition age. 119
SIMULTANEOUS EVALUATION OF THE CIRCULATING LEVELS OF BOTH Th1 AND Th2 CHEMOKINES IN PATIENTS WITH AUTOIMMUNE ADDISON'S DISEASE 117
[Effect of TRH on growth hormone (GH) release induced with ACTH] 115
Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases 114
Autoimmunity as a possible cause of growth hormone deficiency 114
T-lymphocyte-subsets in endocrine exophthalmos 114
[Blood levels of neopterin in patients with liver cirrhosis] 114
Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism 111
Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes 110
Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease 110
Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases 110
[Effect of atropine on hypophyseal gonadotropins in the basal condition and under GnRH stimulation] 110
Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report 109
Medial arterial calcification and diabetic neuropathy 109
[Effect of metoclopramide on growth hormone (GH) release induced with ACTH] 109
COMPORTAMENTO DEL PEPTIDE PROCOLLAGENO III N TERMINALE NEL SIERO DI PAZIENTI CON OFTALMOPATIA BASEDOWIANA CON O SENZA IPERTIROIDISMO 109
Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy 108
Vasopressin cell antibodies and central diabetes insipidus in a patient with systemic lupus erythematosus and dermatomyositis 107
Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' diseas 107
INVOLVEMENT OF HYPOTHALAMUS AUTOIMMUNITY IN PATIENTS WITH AUTOIMMUNE HYPOPITUITARISM: ROLE OF ANTIBODIES TO HYPOTHALAMIC CELLS 106
Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome 106
Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology 105
Inhibiting effect of atropine on prolactin blood levels after stimulation with TRH 105
Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? 104
Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy 104
Rituximab-induced remission of autoimmune hypophysitis and primary immune thrombocytopenia in a patient with autoimmune polyendocrine syndrome type 4 104
Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism 103
Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy 103
Prolactin and autoimmunity 102
[Effect of surgical stress on TSH and on the extra-thyroid metabolism of T4 (preliminary experiment)] 102
Light, blindness and endocrine secretions 101
Antipituitary antibodies in idiopathic hyperprolactinemic patients 100
Serum levels of soluble intercellular adhesion molecule 1 (sICAM-1) as a potential marker of disease activity and remission in patients with chronic hepatitis C 99
New approach study of Graves' Ophtalmopaty: standardized A-Scan echography and Octreotide scintigraphy as possible parameters for disease activi 99
Standardized A-Scan echography and Octreotide scintigraphy are possible parameters for disease activity in Graves' Ophthalmopaty 99
Lymphocytic hypophysitis: a rare or underestimated disease? 98
INCREASED SERUM LEVELS OF PROCOLLAGEN III-N PEPTIDE IN PATIENTS WITH UNTREATED GRAVES’OPHTALMOPATHY WITH OR WITHOUT HYPERTHYROIDISM. 98
Indium-111 octreotide in Graves' disease and in the evaluation of active exophthalmos 97
Sindromi poliendocrine autoimmuni 97
Pituitary Autoimmunity 95
Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth after a long gluten-free diet period: a causal association? 93
Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus 93
Cell-mediated immunity in Graves' disease: evaluation by count of rosette-forming cells 90
Autoimmunità e ipofisi anteriore 90
sELAM-1 e sICAM-1 come possibili markers di predittività per lo sviluppo di IDDM in soggetti con iperglicemia transitoria 90
Totale 12.938
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.921
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021268 0 0 0 0 0 0 0 0 0 144 85 39
2021/2022650 86 3 3 27 230 6 7 16 28 30 52 162
2022/20231.693 153 49 24 185 151 162 0 103 790 15 30 31
2023/2024574 65 29 17 63 183 108 1 19 1 6 29 53
2024/20251.534 9 18 32 67 237 253 197 120 181 184 107 129
2025/20266.922 227 294 390 261 607 4.148 295 375 248 77 0 0
Totale 13.729